3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
11
Prostatic Neoplasms
5
Ovarian Neoplasms
5
Neoplasms
5
Stomach Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Vomiting
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Thromboembolism
1
Thrombocytopenia
1
Stomatitis
1
Spondylitis, Ankylosing
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Scleroderma, Localized
1
Psoriasis
1
Postoperative Hemorrhage
1
Pleural Effusion
1
Peritoneal Neoplasms
1
Pancreatic Cyst
1
Pain, Postoperative
1
Pain
1
Interventions
pembrolizumab
26
atezolizumab
14
Nivolumab
13
Gemcitabine
13
Cisplatin
10
Docetaxel
8
Carboplatin
8
avelumab
7
Mitomycin
7
epacadostat
4
cabozantinib
4
Ipilimumab
4
pemigatinib
3
Specimen Handling
3
Paclitaxel
3
Magnetic Resonance Spectroscopy
3
Bevacizumab
3
vofatamab
2
rucaparib
2
lenvatinib
2
enfortumab vedotin
2
durvalumab
2
cabazitaxel
2
bempegaldesleukin
2
Standard of Care
2
Rogaratinib
2
Ramucirumab
2
Radiation
2
Platinum
2
Pemetrexed
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Transitional Cell
×
Saline Solution
×
Clear all
No trials found.